Similar articles for PMID: 31137917

Year	Number of Results
1990	1
1991	1
1993	1
1994	4
1995	5
1996	4
1997	4
1998	8
1999	5
2000	6
2001	4
2002	5
2003	5
2004	4
2005	7
2006	4
2007	5
2008	5
2009	4
2010	1
2011	2
2012	3
2013	3
2015	1
2016	4
2018	2
2019	6
2020	5
2021	4
2022	3
2023	1
2024	0

1

From Snake Venom's Disintegrins and C-Type Lectins to Anti-Platelet Drugs.

Lazarovici P, Marcinkiewicz C, Lelkes PI. Lazarovici P, et al. Toxins (Basel). 2019 May 27;11(5):303. doi: 10.3390/toxins11050303. Toxins (Basel). 2019. PMID: 31137917 Free PMC article. Review.

2

Functional characteristic of snake venom disintegrins: potential therapeutic implication.

Marcinkiewicz C. Marcinkiewicz C. Curr Pharm Des. 2005;11(7):815-27. doi: 10.2174/1381612053381765. Curr Pharm Des. 2005. PMID: 15777236 Review.

3

Clinical pharmacology of eptifibatide.

Phillips DR, Scarborough RM. Phillips DR, et al. Am J Cardiol. 1997 Aug 18;80(4A):11B-20B. doi: 10.1016/s0002-9149(97)00572-9. Am J Cardiol. 1997. PMID: 9291241 Review.

4

Snake venom probes of platelet adhesion receptors and their ligands.

Wijeyewickrema LC, Berndt MC, Andrews RK. Wijeyewickrema LC, et al. Toxicon. 2005 Jun 15;45(8):1051-61. doi: 10.1016/j.toxicon.2005.02.025. Epub 2005 Apr 19. Toxicon. 2005. PMID: 15922774 Review.

5

Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation.

Okuda D, Morita T. Okuda D, et al. J Biochem. 2001 Sep;130(3):407-15. doi: 10.1093/oxfordjournals.jbchem.a003000. J Biochem. 2001. PMID: 11530017 Free article.

6

Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide.

Batchelor WB, Tolleson TR, Huang Y, Larsen RL, Mantell RM, Dillard P, Davidian M, Zhang D, Cantor WJ, Sketch MH Jr, Ohman EM, Zidar JP, Gretler D, DiBattiste PM, Tcheng JE, Califf RM, Harrington RA. Batchelor WB, et al. Circulation. 2002 Sep 17;106(12):1470-6. doi: 10.1161/01.cir.0000029744.01096.1f. Circulation. 2002. PMID: 12234950 Clinical Trial.

7

A Novel α_IIbβ₃ Antagonist from Snake Venom Prevents Thrombosis without Causing Bleeding.

Kuo YJ, Chung CH, Pan TY, Chuang WJ, Huang TF. Kuo YJ, et al. Toxins (Basel). 2019 Dec 21;12(1):11. doi: 10.3390/toxins12010011. Toxins (Basel). 2019. PMID: 31877725 Free PMC article.

8

From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent.

Kuo YJ, Chung CH, Huang TF. Kuo YJ, et al. Toxins (Basel). 2019 Jun 26;11(7):372. doi: 10.3390/toxins11070372. Toxins (Basel). 2019. PMID: 31247995 Free PMC article. Review.

9

FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.

Huang TF, Chang CH, Ho PL, Chung CH. Huang TF, et al. Exp Hematol. 2008 Dec;36(12):1704-13. doi: 10.1016/j.exphem.2008.07.006. Epub 2008 Sep 21. Exp Hematol. 2008. PMID: 18809237 Free article.

10

Development of eptifibatide.

Scarborough RM. Scarborough RM. Am Heart J. 1999 Dec;138(6 Pt 1):1093-104. doi: 10.1016/s0002-8703(99)70075-x. Am Heart J. 1999. PMID: 10577440 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year